Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-04-03

Clinical Trial Update: Allogeneic Umbilical Cord Blood Therapy for Chronic TBI [NA]

View source ↗

Summary

A clinical trial investigating allogeneic umbilical cord blood therapy for traumatic brain injury was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic Umbilical Cord Blood Therapy

Snippet

Sponsor: Bundang CHA Hospital | Conditions: Traumatic Brain Injury | NA | Status: WITHDRAWN